Assesment of Treatment Outcomes of Aquired Aplastic Anemia in Children : A Retrospective and Prospective Cohort
NCT ID: NCT07131878
Last Updated: 2025-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
35 participants
OBSERVATIONAL
2025-09-15
2028-01-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinico-Epidemiological Profile Of Acquired Aplastic Anemia Among Children At Assiut Governorate .
NCT07259863
A Study to Observe the Causes and Treatment of Anemia in Critically Ill Children
NCT00211055
Iron Status in BTM With Blood Transfusion
NCT04947540
Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
NCT04128943
Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease
NCT00459225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main question it aims to answer is:
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patient diagnosed with aplastic anemia from July 2023 to sept 2025
No interventions assigned to this group
patient diagnosed with aplastic anemia from Sept 2025 to July 2026
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The bone marrow biopsy should be compitable with diagnosis
* Diagnosed and/or treated at Assiut University Children's Hospital between Agust 2023 and Augst 2026.
* Patients with complete medical records, including diagnostic, laboratory, and treatment data
Exclusion Criteria
* Patients with incomplete or missing essential data in their medical records.
* Patients diagnosed outside the specified study period or managed primarily at other institutions.
* Patinets with neoplastic or granulomatous disease involving the bone marrow, systemic lupus erythematosus, AIDS, hypersplenism or other conditions associated with pancytopenia such as myelodysplastic syndrome,and paroxysmal nocturnal hemoglobinuria.
* Patients exposed to antineoplastic chemotherapy or radiotherapy were excluded
1 Year
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Mohamed Abozaid
Resident doctor
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Aquired Aplastic Anemia ttt
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.